• Most Popular
  • Most Shared

InVitria's Cellastim Delivers Superior Results in Mammalian Cell Culture

Thu Sep 25, 2008 9:23pm EDT
FORT COLLINS, Colo., Sept. 25 /PRNewswire/ -- Steve Pettit, Director of
the company's Cell Culture Group, presented results of InVitria's
(http://www.InVitria.com) Cellastim in mammalian cell culture at the 2008
BioProcess International Conference in Anaheim, California this week.
    "Cellastim showed superior results compared to other sources of albumin
and delivered an average of 50% improvement in productivity in CHO cell lines
using variety of the leading chemically defined and animal free medias sold in
the US," said Dr. Steve Pettit, Director of InVitria's Cell Culture Group.
    Studies support InVitria's claim that its Cellastim product, an
animal free recombinant human serum albumin, outperforms other chemically
defined cell culture ingredients and is gaining acceptance by the
biopharmaceutical industry as a supplement for cell culture media. Cellastim
is a defined supplement that can enhance performance of chemically-defined
media.
    Additionally, InVitria's Lacromin product, which is an animal free
recombinant lactoferrin, has proven to be a strong growth factor while
simultaneously enhancing productivity across many cell lines.
    "We continue to show powerful results of Cellastim and Lacromin in cell
culture media for a variety of cell lines including CHO, Hybridoma, Vero and
NS0 cells. Since these are well defined supplements, they help our customers
achieve both their regulatory and manufacturing goals. These are the only
supplements available that not only improve cell culture performance, but do
this while maintaining a defined and animal free media," said Scott Deeter,
InVitria's President.
    To obtain a copy of Dr. Pettit's presentation please contact InVitria by
phone or email at:    1-800-916-8311
    info@InVitria.com

    About InVitria (http://www.InVitria.com)
    InVitria has developed animal free cell culture ingredients that enhance
productivity, safety and time to market for companies in the
biopharmaceutical, cell culture, life science research and diagnostics
industry.
SOURCE  InVitria

InVitria, 1-800-916-8311, info@InVitria.com



More from Reuters

Photo

No U.N. deal on carbon cuts, last day of talks

COPENHAGEN (Reuters) - Two years of U.N. climate talks reached their climax in Copenhagen on Friday without a deal on carbon emissions cuts, as world leaders tried a last push to agree a new global climate pact. | Video

Pedestrians are reflected in a Citigroup window in Boston, Massachusetts. REUTERS/Brian Snyder

Citi's next challenge

Citigroup's plan to extract itself from the government's clutches didn't go as planned. For the bank to succeed, one of two things need to happen.  Full Article 

Aerospace Industries Association President and CEO Marion Blakey makes remarks during the Reuters Aerospace and Defense Summit, December 16, 2009 in Washington.REUTERS/Mike Theiler

"We're not asking for a bailout"

If the U.S. is serious about creating jobs it should invest in aviation programs, says the chief of the Aerospace Industries Association. Just don't call it a bailout.  Full Article